Cost effectiveness analysis in the management of stroke in a tertiary care hospital

Gargi Dey; Jyothi R.; Girish K.

doi:10.18203/2319-2003.ijbcp20194804

Authors

Gargi Dey Department of Pharmacology, Kempegowda Institute of Medical Sciences, Bangalore, Karnataka, India
Jyothi R. Department of Pharmacology, Kempegowda Institute of Medical Sciences, Bangalore, Karnataka, India
Girish K. Department of Pharmacology, Kempegowda Institute of Medical Sciences, Bangalore, Karnataka, India

DOI:

https://doi.org/10.18203/2319-2003.ijbcp20194804

Keywords:

Cost of illness, Stroke, Direct costs

Abstract

Background: Stroke has a high economic impact on the society especially in a developing country like India. In India health insurance doesn’t cover all people leading to out of pocket expenditure. The objective of the present study was to study the cost of illness and outcome of stroke in a tertiary care hospital.

Methods: Direct medical and nonmedical costs were obtained after 28 days of follow-up. The outcome of the stroke was measured by modified Rankin scale (mRS).

Results: The mean age of the patients was 65.38±13.98 years. Majority of the patients suffered from ischemic stroke and belonged to lower middle socioeconomic group. The mean cost of stroke was INR 39819. There was improvement in the mRS score after 28 days following treatment of acute stroke.

Conclusions:Direct medical costs forms major component of cost of stroke. Early management and hospital discharge can reduce the economic burden of stroke.

Metrics

Metrics Loading ...

References

Feigi VL, Norrving B, Mensah GA. Global Burden of Stroke. 2017;120:439-48.

Kwatra G, Kaur P, Toor G, Badyal DK, Kaur R, Singh Y, et al. Cost of stroke from a tertiary center in northwest India. Neurol India. 2013;61(1):627-32.

Powar PV, Nagare A, Ambikar RB, Sharma PH, Vyawahare NS. Pharmacoeconomics- costs of drug therapy to healthcare systems. J Modern Drug Discovery Drud Delivery Res. 2014;1(2):2348-3776.

Mudhaliar MR, Swarnakumari D, Yiragamreddy PR, Venkataramana B. Drug evaluation and appropriateness of medication used in stroke patients. WJPMR. 2016;2(5):168-74.

Himaja J, Rakesh B. A study of clinical profile, risk factors and drug utilisation pattern in cerebrovascular stroke. Eur J Biomed Pharm Sci. 2017;4:258-73.

Miah MN, Azhar MA, Rahman A, Haldar D, Akteruzzaman M, Kundu NC. Risk factors of stroke in young and old age group- a comparative study. J Med. 2012;13:138-42.

Sharma M, Lal M, Singh T, Deepti SS. Factors associated with physical and psychosocial problems among Indian stroke survivors. Indian J Palliative Care. 2019;25(1):18-23.

Kumar A, Prasad M, Kathuria P, Nair P, Pandit AK, Sahu JK, et al. Low socioeconomic status is an independent risk factor for ischemic stroke: a case-control study in North Indian population. Neuroepidemiol. 2015;44:138-43.

Yoneda Y, Uehara T, Yamasaki H, Kita Y, Tabuchi M, Mori E. Hospital-based study of the care and cost of acute ischemic stroke in Japan. Stroke. 2003;34:718-24.

Chang KC, Lee HC, Huang YC, Hung JW, Chiu HE, Chen JJ, et al. Cost-effectiveness analysis of stroke management under a universal health insurance system. J Neurol Sci 2012;323(1-2):205-15.

Housley SN, Garlow AR, Ducote K, Howard A, Thomas T, Wu D, et al. Increasing access to cost effective home-based rehabilitation for rural veteran stroke survivors. Aus J Cerebrovas Dis Stroke. 2016;3(2):1-11.

Many routinely prescribed treatments for stroke patients are costly are not supported solid evidence according to investigators. Can Clincians reduce in-hospital care costs for stroke patients?. Neurology Reviews. 2012;20(10):17.

Dey G, Jyothi R, Kumar BNP, Girish K. A retrospective observational study of the effect of physiotherapy treatment on outcomes in stroke patients. Natl J Physiol Pharm Pharmacol. 2019;9(8):780-3.